ENTRY INHIBITORS OF THE HIV VIRUS

The present invention relates to small molecules as entry inhibitors of the HIV virus, processes for their preparation as well as pharmaceutical compositions, their use as medicines, and diagnostic kits comprising them. The present invention also concerns combinations of the present entry inhibitors...

Full description

Saved in:
Bibliographic Details
Main Authors VAN ACKER, KOENRAAD LODEWIJK AUGUST, TAHRI, ABDELLAH, WIGERINCK, PIET TOM BERT PAUL, MICHIELS, LIEVE EMMA JAN
Format Patent
LanguageEnglish
French
Published 27.11.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to small molecules as entry inhibitors of the HIV virus, processes for their preparation as well as pharmaceutical compositions, their use as medicines, and diagnostic kits comprising them. The present invention also concerns combinations of the present entry inhibitors with other anti-retroviral agents. It further relates to their use in assays as reference compounds or as reagents. The compounds of the present invention are useful for preventing or treating infection by HIV and for treating AIDS. The compounds of formula (I) have the following structure: (I).
AbstractList The present invention relates to small molecules as entry inhibitors of the HIV virus, processes for their preparation as well as pharmaceutical compositions, their use as medicines, and diagnostic kits comprising them. The present invention also concerns combinations of the present entry inhibitors with other anti-retroviral agents. It further relates to their use in assays as reference compounds or as reagents. The compounds of the present invention are useful for preventing or treating infection by HIV and for treating AIDS. The compounds of formula (I) have the following structure: (I).
Author WIGERINCK, PIET TOM BERT PAUL
MICHIELS, LIEVE EMMA JAN
VAN ACKER, KOENRAAD LODEWIJK AUGUST
TAHRI, ABDELLAH
Author_xml – fullname: VAN ACKER, KOENRAAD LODEWIJK AUGUST
– fullname: TAHRI, ABDELLAH
– fullname: WIGERINCK, PIET TOM BERT PAUL
– fullname: MICHIELS, LIEVE EMMA JAN
BookMark eNrjYmDJy89L5WRQdPULCYpU8PTz8HTyDPEPClbwd1MI8XBV8PAMUwjzDAoN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORqbGhuZmZs7GhFUAAGpWIws
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE LA PENETRATION DU VIRUS VIH
ExternalDocumentID CA2531766C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2531766C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2531766C3
Notes Application Number: CA20042531766
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121127&DB=EPODOC&CC=CA&NR=2531766C
ParticipantIDs epo_espacenet_CA2531766C
PublicationCentury 2000
PublicationDate 20121127
PublicationDateYYYYMMDD 2012-11-27
PublicationDate_xml – month: 11
  year: 2012
  text: 20121127
  day: 27
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies TIBOTEC PHARMACEUTICALS LTD
RelatedCompanies_xml – name: TIBOTEC PHARMACEUTICALS LTD
Score 2.8698153
Snippet The present invention relates to small molecules as entry inhibitors of the HIV virus, processes for their preparation as well as pharmaceutical compositions,...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ENTRY INHIBITORS OF THE HIV VIRUS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121127&DB=EPODOC&locale=&CC=CA&NR=2531766C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7UatSbVk19r4nhRmzpwtIDMWWBgEmhoZTUU8MzeqmNxfj3nSWgXnrb7Cazu5OZ-fb1zQI8qpSVGPkLuUS0l6k61OUUcUbWMzQgNJAxHQm-89TX3AV9WarLDry1XJg6T-h3nRwRPSpDf6_qeL35O8Sy6reV26f0Has-np3IsKRmdyzylSlMskzDngVWwCXODT6R_NBQ0NaYpvE92MdFNBO-YMem4KRs_gOKcwIHM5S1rk6hU6x7cMTbf9d6cDhtrrux2Hje9gwebD8KX4nnu57pRUE4J4FDItcmrheT2AsX83O4d-yIuzL2tfqd1opP2kGNLqCLm_2iD0SjSZ4OkmFepgpleZ4IcmhGtVwblwUd6JfQ3yXlanfTNRwL5QgOncJuoFt9fhW3CKZVelfr4QdPLHRr
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3rZr6LCaGG7Gly6MHYsoCAS3QUNrUE-GZeqmNxfj3nSWgXnrb7Cazu5OZ-fb1zQI8SkQpMPLnQoFoLxBpqAoJ4oygpmhAaCBjMmJ8Z9eT7QV5WUmrFqwbLkyVJ_S7So6IHpWiv5dVvN7-HWIZ1dvK3VPyjlUfz1aoGXy9O2b5ykSFN3TNnPmGT3lKNTrhvUAT0dYUWaYHcIgLbIX5grnUGSdl-x9QrFM4mqGsTXkGrXzThQ5t_l3rwrFbX3djsfa83Tk8mF4YvHGOZzu6E_rBnPMtLrRNznaW3NIJFvML6FtmSG0B-4p-pxXRSTOo0SW0cbOf94CTSZwlg3iYFYlIlCyLGTk0JXImj4ucDNQr6O2Tcr2_qQ8dO3Sn0dTxXm_ghCmK8elE5Rba5edXfofAWib3lU5-AO9Rd14
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ENTRY+INHIBITORS+OF+THE+HIV+VIRUS&rft.inventor=VAN+ACKER%2C+KOENRAAD+LODEWIJK+AUGUST&rft.inventor=TAHRI%2C+ABDELLAH&rft.inventor=WIGERINCK%2C+PIET+TOM+BERT+PAUL&rft.inventor=MICHIELS%2C+LIEVE+EMMA+JAN&rft.date=2012-11-27&rft.externalDBID=C&rft.externalDocID=CA2531766C